IRON Logo

Disc Medicine, Inc. (IRON) 

NASDAQ
Market Cap
$1.93B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
41 of 959
Rank in Industry
33 of 550

Largest Insider Buys in Sector

IRON Stock Price History Chart

IRON Stock Performance

About Disc Medicine, Inc.

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Insider Activity of Disc Medicine, Inc.

Over the last 12 months, insiders at Disc Medicine, Inc. have bought $14M and sold $25.51M worth of Disc Medicine, Inc. stock.

On average, over the past 5 years, insiders at Disc Medicine, Inc. have bought $12M and sold $28.02M worth of stock each year.

Highest buying activity among insiders over the last 12 months: ORBIMED ADVISORS LLC (director) — $126M. Bitterman Kevin (director) — $24M. Ashiya Mona (director) — $3M.

The last purchase of 222,223 shares for transaction amount of $8M was made by Bitterman Kevin (director) on 2024‑06‑17.

List of Insider Buy and Sell Transactions, Disc Medicine, Inc.

2024-12-16SaleChief Executive Officer
12,791
0.0431%
$66.01$844,314-2.54%
2024-12-02Saledirector
1,957
0.0066%
$64.63$126,490+0.75%
2024-11-25SaleChief Medical Officer
14,183
0.0492%
$65.45$928,326+0.08%
2024-11-15SaleChief Medical Officer
9,158
0.0289%
$59.64$546,153+8.48%
2024-11-04Saledirector
7,136
0.0221%
$58.61$418,206+10.70%
2024-11-01Saledirector
201
0.0005%
$46.37$9,319+36.77%
2024-10-01Saledirector
201
0.0005%
$51.31$10,312+16.61%
2024-09-16SaleChief Medical Officer
1,500
0.0038%
$47.41$71,115+10.59%
2024-09-03SaleChief Medical Officer
1,500
0.004%
$50.59$75,885+2.13%
2024-09-03Saledirector
1,957
0.0051%
$49.65$97,158+2.13%
2024-08-01Saledirector
201
0.0005%
$43.44$8,731+14.57%
2024-07-01Saledirector
201
0.0005%
$46.04$9,253+4.72%
2024-06-17Purchasedirector
83,334
0.1589%
$36.00$3M+7.24%
2024-06-17Purchasedirector
83,334
0.1589%
$36.00$3M+7.24%
2024-06-17Purchasedirector
222,223
0.4237%
$36.00$8M+7.24%
2024-06-03Saledirector
1,957
0.0037%
$36.08$70,608+32.16%
2024-05-01Saledirector
201
0.0003%
$28.63$5,755+65.97%
2024-04-11Saledirector
2,560
0.0043%
$31.80$81,407+46.54%
2024-03-05Saledirector
26,157
0.1018%
$73.50$1.92M-31.68%
2024-01-23Saledirector
102,500
0.3672%
$67.65$6.93M-27.35%

Insider Historical Profitability

100.92%
ORBIMED ADVISORS LLCdirector
941569
3.1641%
$65.0110
Ashiya Monadirector
941569
3.1641%
$65.0110
Bitterman Kevindirector
420549
1.4132%
$65.0112
AI DMI LLC10 percent owner
3141759
10.5578%
$65.0110+100.92%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.